Medical devices manufactured by the Sebbin Group

Safety warning - Medical devices manufactured by the Sebbin Group

The Division of Pharmacy and Medicines (Division de la pharmacie et des médicaments - DPM) was informed by the French National Agency for the Safety of Medicinal and Health Products (Agence nationale de sécurité du médicament et des produits de santé - ANSM) that the Sebbin Group had ceased trading further to being placed in compulsory liquidation. Sebbin stopped manufacturing and marketing all of its products, including its breast implants, on 3 March 2025.

The list of medical devices manufactured by the Sebbin Group can be found at the bottom of this page, in the 'More information' box.

According to the information provided by ANSM, Sebbin medical devices that were manufactured before 3 March 2025 – the date on which the CE mark certificate expired – can still be used and implanted, but will not be covered by the manufacturer's commercial warranties.

Sebbin ceased trading for commercial reasons, rather than for product-safety reasons. Sebbin products that were manufactured before 3 March 2025 meet the applicable general safety and performance requirements.

What should patients do

  • Talk to your doctor or a healthcare professional about any concerns you might have in this regard.
  • If you become aware of any side effects in relation to a Sebbin device, contact your doctor or a healthcare professional.
  • Please report any incidents that occur with your Sebbin device to the DPM, at meddevices.vigilance@ms.etat.lu, using the dedicated Notification Form (Word, 181 Kb) (FR/DE).

'Incident' should be understood to mean any malfunction or alteration in the characteristics or performance of a device placed on the market, including errors in use due to its ergonomic features, lack of manufacturer information, and side effects.

'Serious incident' should be understood to mean any incident that resulted in, could have resulted in, or is likely to result in, either directly or indirectly:

  • The death of a patient, a user or any other person;
  • A temporary or permanent serious deterioration in a patient's, user's or other person's health;
  • A serious threat to public health.

Guidance on filling in the notification form, and a document on data protection, are also available:

Last update